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Introduction
The obligate intracellular pathogen Chlamydia trachomatis is the 
cause of preventable blindness (trachoma; Wright et al., 2008)   
and is responsible worldwide for up to 90 million cases per year 
of sexually transmitted disease (Brunham and Rey-Ladino, 2005). 
C. trachomatis exhibits a unique biphasic developmental cycle, 
which is initiated by the infectious elementary bodies (EBs). Once   
engulfed by the host cell, EBs differentiate into actively repli-
cating reticulate bodies (RBs) within a protective vacuole called 
the inclusion. RBs eventually redifferentiate to form EBs, which 
are released ready to infect new cells.
Gram-negative bacteria such as Chlamydia are known to ex-
press and secrete host interactive proteins via type III or type IV 
secretion systems into the host cell cytoplasm to modulate host 
cell processes (Hueck, 1998; Christie et al., 2005). Some of 
these effector proteins become phosphorylated upon host cell 
entry, such as the translocated intimin receptor (Tir) of entero-
pathogenic Escherichia coli (EPEC; Kenny et al., 1997) and the 
cytotoxicity-associated gene A (CagA) of Helicobacter pylori 
(Asahi et al., 2000). C. trachomatis uses a type III system to   
secrete  numerous  effector  proteins  (Valdivia,  2008).  One  of 
these, the translocated actin-recruiting phosphoprotein (Tarp), 
becomes tyrosine phosphorylated upon entry of C. trachomatis 
into the host cell (Clifton et al., 2004). To date, several host cell 
kinases have been implicated in Tarp phosphorylation including 
SRC, ABL, and SYK (Elwell et al., 2008; Jewett et al., 2008; 
Mehlitz et al., 2008), and the number of Tarp phosphorylation 
sites varies between Chlamydia species and serovars (Jewett   
et al., 2008).
M
any  bacterial  pathogens  translocate  effector 
proteins into host cells to manipulate host cell 
functions. Here, we used a protein microarray 
comprising virtually all human SRC homology 2 (SH2) 
and phosphotyrosine binding domains to comprehensively 
and quantitatively assess interactions between host cell pro-
teins and the early phase Chlamydia trachomatis effector 
protein  translocated  actin-recruiting  phosphoprotein 
(Tarp), which is rapidly tyrosine phosphorylated upon host 
cell entry. We discovered numerous novel interactions 
between  human  SH2  domains  and  phosphopeptides 
derived from Tarp. The adaptor protein SHC1 was among 
Tarp’s strongest interaction partners. Transcriptome analysis 
of SHC1-dependent gene regulation during infection indi-
cated that SHC1 regulates apoptosis- and growth-related 
genes. SHC1 knockdown sensitized infected host cells 
to tumor necrosis factor–induced apoptosis. Collectively, 
our findings reveal a critical role for SHC1 in early   
C. trachomatis–induced cell survival and suggest that Tarp 
functions as a multivalent phosphorylation-dependent 
signaling hub that is important during the early phase of 
chlamydial infection.
Tarp regulates early Chlamydia-induced host 
cell survival through interactions with the human 
adaptor protein SHC1
Adrian Mehlitz,
1,2 Sebastian Banhart,
1 André P. Mäurer,
1 Alexis Kaushansky,
3 Andrew G. Gordus,
3 Julia Zielecki,
1 
Gavin MacBeath,
3 and Thomas F. Meyer
1
1Department of Molecular Biology, Max Planck Institute for Infection Biology, 10117 Berlin, Germany
2Department of Microbiology, Biocenter, University of Würzburg, 97074 Würzburg, Germany
3Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138
©  2010  Mehlitz  et  al.  This  article  is  distributed  under  the  terms  of  an  Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub-
lication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
YJCB • VOLUME 190 • NUMBER 1 • 2010   144
Figure 1.  Quantitative protein interaction mapping. Quantitative data were obtained by probing SH2/PTB domain microarrays with fluorescently labeled 
peptides derived from Tarp. The resulting data were used to construct quantitative protein interaction maps. White circles within the square represent   
peptides derived from C. trachomatis. Peptide allocation can be derived from Table S1 and the peptide legend, which shows phosphorylation status and 145 Tarp phospho-interactome • Mehlitz et al.
position within the full-length protein. For example, peptide 2 in A mimics the three identical ENIYE repeats of serovar D Tarp in the nonphosphorylated state. 
Green and blue circles around the square represent individual SH2 and PTB domains, respectively. Circles outside the square indicate tandem domains (the 
corresponding spot on the protein array contains both domains), which are connected to their individual domains (i.e., full-length SYK is in possession of 
two SH2 domains located either N or C terminally). A color-coded line is used to reflect the measured interaction strength between each domain–peptide 
pair (n = 2). Exact values are provided in Table S1. Interactions with KD ≥ 2 µM are omitted. (A and B) Interaction maps of nonphosphorylated Tarp D and 
L2. (C and D) Interaction maps of singly phosphorylated Tarp D and L2. (E) Interaction map of doubly phosphorylated Tarp from serovariant L2.
 
Although Chlamydia species continue to be refractory to 
genetic manipulation (Heuer et al., 2003), Tarp’s function has 
been assessed using the heterologous type III secretion system 
of Yersinia pseudotuberculosis (Clifton et al., 2004). This study 
revealed a critical role of Tarp in the actin-driven uptake of   
bacteria by host epithelial cells. Tyrosine phosphorylation of 
Tarp, however, appears to be uncoupled from actin polymer-
ization because nonphosphorylated Chlamydophila pneumonia 
Tarp still induces actin polymerization (Clifton et al., 2005).   
Instead, actin polymerization is thought to be stimulated through 
oligomerization of a WAVE2-like actin-binding domain in the 
C terminus of the protein (Jewett et al., 2006), and Tarp phosphory-
lation takes place at multiple N-terminal motifs (Jewett et al., 
2008). Phosphotyrosine-containing motifs are known to interact 
with SRC homology 2 (SH2) or phosphotyrosine binding (PTB) 
domains of signaling proteins (Schlessinger and Lemmon,   
2003). Phosphorylation of Tyr179 and Tyr189 of Tarp has pre-
viously been implicated in recruiting the RAC guanine nucleotide   
exchange factor VAV2 and the regulatory subunit of phosphatidyl-
inositol 3-kinase (PI3K; Lane et al., 2008). These interactions   
are thought to participate in a redundant invasion mechanism. 
Paradoxically, however, cell entry is independent of Tarp phosphory-
lation (Clifton et al., 2005; Jewett et al., 2006). A more compre-
hensive  analysis  of  phosphotyrosine-mediated  interactions  is 
therefore necessary to establish Tarp’s functional repertoire.
A prerequisite of Chlamydia replication is the pathogen’s 
ability to prevent apoptosis of its host cell. C. trachomatis– 
infected cells become resistant to numerous pro-apoptotic stim-
uli, including staurosporine, etoposide, TNF, FAS antibody, and 
granzyme B/perforin (Fan et al., 1998). Anti-apoptotic activity 
is thought to be conveyed by the proteolytic degradation of the 
pro-apoptotic BH3-only proteins BIM/BOD and PUMA and by 
the mitochondrial sequestration of BAD during chlamydial in-
fection (Fischer et al., 2004). Alternatively, recent studies have 
implicated the anti-apoptotic BCL-2 family member MCL-1 as 
a key factor in preventing apoptosis (Rajalingam et al., 2008). 
In addition, Chlamydia subverts the function of the pro-apoptotic 
PKC by increasing diacylglycerol levels in the chlamydial inclu-
sion membrane (Tse et al., 2005). Together, these observations sug-
gest that Chlamydia prevents host cell apoptosis through a variety 
of mechanisms, likely acting sequentially as infection proceeds 
(Fan et al., 1998; Perfettini et al., 2002; Rajalingam et al., 2008).
An important pathway modulating host cell apoptosis and 
survival is the RAS/RAF/MEK/ERK MAPK signaling cascade. 
C. trachomatis infection leads to extracellular signal-regulated 
kinase (ERK) activation, followed by the downstream activa-
tion of cytosolic phospholipase A2 (cPLA2; Su et al., 2004), the 
induction of interleukin-8 (IL-8; Buchholz and Stephens, 2008), 
TNF receptor 1 (TNFR1) shedding (Paland et al., 2008), and 
stabilization of MCL-1 (Rajalingam et al., 2008). Recent work 
has revealed that MEK (MAPK/ERK kinase)/ERK activation   
is independent of RAS/RAF during mid and late C. trachomatis  
infection (Gurumurthy et al., 2010). Upon activation, MEK1/2 
phosphorylates ERK1/2 at specific tyrosine and threonine resi-
dues, which then directly phosphorylates a variety of transcription   
factors including c-JUN, c-MYC, and nuclear factor B (NF-B). 
The SRC homology containing protein SHC1 represents a molec-
ular adapter, linking extracellular signals to mitogenic responses 
(Pelicci et al., 1992). SHC1 exists as three isoforms, all encoded 
by a single gene locus (Luzi et al., 2000). The isoforms share a 
common domain composition: a C-terminal SH2 domain, an   
N-terminal PTB domain, and a central collagen-homology domain 
(CH1)  harboring  several  phosphorylation  sites  (Ravichandran, 
2001). Interaction at these sites with growth factor receptor-bound 
protein 2 (GRB2), in conjunction with the RAS exchange factor 
SOS, activates the RAS/RAF/MEK/ERK pathway to induce a   
mitogenic response (van der Geer et al., 1996).
Here,  we  used  a  systematic  approach  to  discover  and 
quantify  phosphorylation-dependent  interactions  between 
the bacterial effector protein Tarp and host cell SH2/PTB   
domain–containing proteins. We found that Tarp interacts with 
a variety of SH2 domain–containing proteins, which suggests 
it functions as a multivalent signaling hub. SHC1 was identi-
fied as one of the strongest interaction partners of phosphory-
lated Tarp derived from both chlamydial serovariants L2 and D. 
Knockdown of SHC1 sensitized C. trachomatis-infected cells 
to apoptosis at an early stage of the chlamydial developmental 
cycle and blocked induction of cell growth–related gene ex-
pression. SHC1-mediated cell survival and gene regulation was   
found to be controlled through both MEK/ERK-dependent 
and -independent signaling. Thus, C. trachomatis confers resis-
tance to pro-apoptotic stimuli upon host cells during the early 
stages of infection. This facet of apoptosis resistance appears 
to be mediated by Tarp’s interactions with SHC1.
Results
Peptide design of Tarp phosphorylation sites
To identify the cellular interaction partners of Tarp, we synthe-
sized fluorescently labeled peptides representing the N-terminal   
sites  of  tyrosine  phosphorylation  on Tarp.  C.  trachomatis  
D Tarp features three identical ENIYE motifs at tyrosine residues 
Y171, Y221, and Y271 (Fig. 1 A), whereas C. trachomatis L2 
Tarp features nine sites of tyrosine phosphorylation at residues 
Y136, Y140, Y189, Y239, Y242, Y291, Y341, Y390, and Y394 
(Fig. 1 B). Six of these nine C. trachomatis L2 phosphoryla-
tion sites—Y136/140, Y238/242, and Y390/394—are double-
phosphorylation sites of the primary sequence ENIYENIYESI   
(Fig. 1 B). Eight peptides, each comprising 18 amino acids sur-
rounding the respective phosphorylation sites, were synthesized JCB • VOLUME 190 • NUMBER 1 • 2010   146
Figure 2.  Quantitative analysis of the phospho-interactome. Interaction networks of the phospho-states from Fig. 1 were binned using three different   
affinity thresholds (KD < 500 nM, KD < 1000 nM, and KD < 1500 nM). In A–C, only peptide–domain interactions below the stated threshold are shown 
(red lines). Edge nodes are colored as in Fig. 1. p-Tarp D refers to phosphorylated Tarp from C. trachomatis serovariant D; p-Tarp L21 and L22 refer to 
singly and doubly phosphorylated Tarp from serovariant L2, respectively. (A) Tarp D is less promiscuous than Tarp L2 and has few interaction partners at 
all affinity thresholds. (B) Tarp L21 exhibits highly promiscuous binding even at the highest affinity threshold (KD < 500 nM). (C) Tarp L22 has fewer high-
affinity interaction partners (KD < 500 nM) than Tarp L21, but the number of interactors increases sharply as the affinity threshold is relaxed. To the right, 
the number of Tarp interaction partners at each affinity threshold is depicted in bar diagrams. Multiple domains from proteins interacting with more than   
one phospho-site are only counted once. (D–G) Venn diagrams showing the number of overlapping interactions (white) between nonphosphorylated 
Tarp D (red) and L2 (green) (D), singly phosphorylated Tarp D (red) and L21 (green) (E), singly phosphorylated Tarp D (green) and doubly phosphorylated 
L22 (blue) (F), and singly phosphorylated Tarp L21 (green) and doubly phosphorylated L22 (blue) (G).147 Tarp phospho-interactome • Mehlitz et al.
in their non-, singly, or doubly phosphorylated states (Table S1). 
A fluorescent dye was coupled to the N terminus of each peptide 
for detection purposes (see Materials and methods). These pep-
tides were then used to investigate interactions with human SH2 
and PTB domains.
Quantitative interactome analysis
To identify and quantify interactions between Tarp-derived pep-
tides and human signaling proteins, we probed protein micro-
arrays comprising 133 SH2 and PTB domains in duplicate with 
eight concentrations of each Tarp-derived peptide, and then fit 
the observed fluorescence data, Fobs, to an equation that de-
scribes saturation binding, as described previously (Jones et al., 
2006). This enabled us to measure binding affinities between 
every peptide and every recombinant domain. From the result-
ing quantitative dataset, we constructed a graphical representa-
tion of biophysical interactions with phospho-sites on the D and 
L2 serovariants of Tarp (Fig. 1). Three Tarp phosphorylation 
states were defined: nonphosphorylated (Fig. 1, A and B), singly 
phosphorylated (Fig. 1, C and D), and doubly phosphorylated 
(Fig. 1 E). Because not all SH2/PTB domain–containing proteins 
are expressed at appreciable levels in every cell type or at every 
subcellular location, these diagrams should be viewed as quan-
titative maps of potential Tarp interactions in the context of par-
ticular cell expression patterns.
Nonphosphorylated peptides derived from both Tarp D 
and Tarp L2 exhibited very few interactions with human SH2 
and PTB domains, as anticipated. Most notably, the tyrosine kinase 
ABL2 (ARG) and the GTPase-activating protein RASA1 inter-
acted with Tarp peptides (Fig. 1, A and B; and Table S1). By prob-
ing the arrays with the singly phosphorylated version of the 
Tarp D peptide, the affinity of its interaction with ABL2 increased 
and several new interactions appeared, including a high affinity 
interaction with the SH2 domain of SHC1 (KD < 200 nM) and 
interactions with the SH2 domains of CRKL, ABL1, SHC3, and 
RASA1. Even more dramatic changes were observed with 
phosphorylated Tarp L2 peptides. Numerous high affinity inter-
actions occurred, most notably with the SH2 domains of ABL1, 
ABL2, FGR, SYK, HCK, YES1, GRB2, CRKL, NCK2, SHB, 
TENC1, RASA1, VAV2, and SHC1; and with all three isoforms 
of the regulatory subunit of PI3K (Fig. 1 D). Interestingly, the 
incremental effect of introducing the doubly phosphorylated 
peptide was minimal: only minor changes in affinities for some 
interaction  partners  (e.g., VAV2,  PI3KR2,  SYK,  and  HCK) 
were observed (Fig. 1 E and Table S1). This observation is con-
sistent with our previous findings that doubly phosphorylated 
peptides derived from a variety of human receptor tyrosine kinases 
behave similarly as compared with their singly phosphorylated 
counterparts (Jones et al., 2006). Notably, no PTB domains rec-
ognized any of the Tarp-derived peptides, except the PTB   
domain of IRS1, which recognized the doubly phosphorylated 
peptide derived from Tarp L2 (Fig. 1 E). Our data suggest that 
Tarp proteins may have been evolutionarily optimized to recog-
nize SH2 domains that preferentially bind sequences C-terminally 
of phosphotyrosines (Sudol, 1998).
To highlight differences in binding affinities, the inter-
action maps for Tarp D, Tarp L21 (singly phosphorylated), 
and  Tarp  L22  (doubly  phosphorylated)  were  prepared  using 
three different affinity thresholds (Fig. 2, A–C). Tarp D exhib-
ited high-affinity interactions (KD < 500 nM) with two proteins   
(Fig. 2 A), increasing to six as the threshold was relaxed to 
1,500 nM (Fig. 2 A). In contrast, Tarp L21 (singly phosphory-
lated) exhibited promiscuous binding even at the highest affinity 
threshold  (Fig.  2  B).  Surprisingly,  hyperphosphorylation  of 
Tarp L2 decreased the number of high-affinity interactions, but 
the overall number of interaction partners for Tarp L22 sharply 
increased as the affinity threshold was relaxed (Fig. 2 C). Com-
parison of the different sets of interaction partners for both   
Tarp serovariants (Tarp D and L2) revealed two common inter-
action partners in the nonphosphorylated state (Fig. 2 D), and 
a core set of six proteins in the phosphorylated state (Fig. 2 E). 
This set included the adaptor protein SHC1, which bound both  
serovariants with high affinity. Tarp L21 and L22 were both found 
to interact with all of the phospho–Tarp D binding partners   
(Fig. 2, E and F), which suggests that signaling initiated by the 
Tarp D serovariant constitutes a subset of the signaling initiated 
by Tarp L2. Tarp L21 and L22 were very similar, with 17 inter-
action partners in common (Fig. 2 G).
To identify signaling pathways that are potentially activated 
by Tarp, we used Ingenuity Pathway Analysis (IPA) software 
and the Kyoto Encyclopedia of Genes and Genomes (KEGG; 
http://www.genome.jp/kegg/).  Signaling  pathways  associated 
with at least two Tarp interaction partners were used to construct 
a qualitative model of Tarp-mediated signaling. Both serovariants 
of Tarp were found to interact with proteins commonly associ-
ated with EGF receptor (EGFR) signaling and MAPK signaling 
(Fig. S1, A–C). Interestingly, Tarp L2 also interacted with pro-
teins associated with immune signaling pathways of B and T cells, 
as well as with innate immune responses of natural killer cells, 
macrophages, and neutrophils (Fig. S1, B and C). Connection of 
Tarp L2 with these additional signaling pathways derives mainly 
from interactions mediated by its doubly phosphorylated state 
(Fig. S1, B and C).
Overall, we found that phosphorylation of Tarp enables   
multiple high-affinity interactions with human SH2 domains; that a 
core set of proteins involved in MAPK signaling is able to interact 
with both serovariants of Tarp; and that signaling initiated by Tarp 
D likely constitutes a subset of the signaling initiated by Tarp L2.
Validation of interactions between Tarp and 
selected host cell proteins
To test whether the identified protein interactions have relevance 
for chlamydial infection, we selected the strongest interaction 
partner of both serovariants of Tarp, SHC1, and a serovariant 
L2-specific interaction partner, NCK2, for further experimental 
validation. Heterologously expressed GST fused to Tarp from 
C. trachomatis serovariants D and L2 (Fig. 3 A) was coupled to 
beads, phosphorylated in vitro by SRC kinase, and incubated 
with host cell lysate. Truncated versions of N-terminal Tarp were 
used to avoid the actin-nucleating activity of the C-terminal   
region (Jewett et al., 2006) and additional interaction of cellular 
proteins with any noncharacterized Tarp motifs. Both phosphory-
lated Tarp D and Tarp L2 bound SHC1 and showed a strong 
preference for the SHC1
p52 isoform (Fig. 3 B). In contrast, only JCB • VOLUME 190 • NUMBER 1 • 2010   148
SHC1 phosphorylation was significantly increased during in-
fections with C. trachomatis but not C. pneumoniae (Fig. 4 C). 
Interestingly, the SHC1
p52 isoform was most rapidly and most 
strongly phosphorylated by C. trachomatis (Fig. 4 A), which is 
consistent with the observed binding preference of Tarp L2 and D 
(Fig. 3 B). Furthermore, immunofluorescence staining experiments 
showed that SHC1 activation was accompanied by recruitment of 
the protein to bacteria during host cell entry (Fig. S2, B and C).
Both SHC1 phosphorylation (van der Geer et al., 1996) 
and C. trachomatis infection (Su et al., 2004) have been shown 
to activate the MEK/ERK cascade; however, C. trachomatis– 
induced MEK/ERK activation has mainly been demonstrated   
at later infection time points, e.g., from 12 h pi (Paland et al., 
2008). Because Tarp is secreted within minutes after attach-
ment, we investigated MEK and ERK activation during this 
early phase of infection. Both MEK and ERK phosphorylation 
increased sharply 5–10 min pi in HeLa (Fig. 4, D–F) and End1/
E6E7 cells (primary immortalized endocervical cells; unpub-
lished data), then decreased to 20% and 10% above basal 
levels for MEK and ERK, respectively, after 1 h. MEK/ERK 
activation was dependent on MOI (unpublished data).
The role of SHC1 in infection and C. trachomatis–induced 
early MEK/ERK activation was further examined by siRNA-
mediated knockdown of SHC1. Upon C. trachomatis infection, 
SHC1  knockdown  reduced  MEK  and  ERK  phosphorylation 
(Fig. 4, G and H). A similar degree of reduction occurred after 
stimulation of noninfected SHC1 knockdown cells with inducers 
phosphorylated Tarp L2 was capable of precipitating NCK2 
(Fig. 3 B). This is consistent with the array data because peptides 
derived from phospho-sites on Tarp L2, but not Tarp D, were 
recognized by the SH2 domain of NCK2. We focused on SHC1, 
the common interaction partner of both serovariants, and found, 
in a coimmunoprecipitation experiment, that endogenous SHC1 
and Tarp L2 coprecipitated from two separate C. trachomatis–
infected cell types (Fig. 3 C). These experiments show that the 
interactions with SHC1 and NCK2 highlighted by the protein 
microarrays are also observed with full-length proteins.
SHC1 activation and influence on MEK/ERK 
signaling during C. trachomatis cell entry
Next, we assessed the influence of Tarp–SHC1 interaction on 
major downstream signaling pathways by investigating the activa-
tion of the MEK/ERK cascade upon phosphorylation of SHC1. 
As previously shown, recruitment of SHC1 to endogenous human 
receptors leads to its phosphorylation on Tyr239/240 and Tyr317 
(van der Geer et al., 1996). To test SHC1 activation during   
C. trachomatis infection, time course experiments were performed 
in HeLa cells. All three SHC1 isoforms were phosphorylated on 
Tyr239/240 during invasion of C. trachomatis (Fig. 4 A) for up 
to 5 h postinfection (pi; Fig. S2 A). In contrast, during infection 
with  C.  pneumoniae,  which  translocates  a  Tarp  homologue 
(Cpn0572)  lacking  the  phosphorylation  sites  (Clifton  et  al., 
2005), SHC1 phosphorylation was only marginally increased 
(Fig. 4 B). Quantification of Western blotting data revealed that 
Figure 3.  SHC1 is an interaction partner of Tarp D and L2. (A) Graphical representation of Tarp D and L2 and the respective GST–Tarp fusion proteins in-
cluding all phospho-sites. Truncated versions of Tarp were used to avoid the actin-nucleating activity of the C terminus (Jewett et al., 2006) and any unknown 
binding regions. (B) Western blot showing pull-down of SHC1 and NCK2 from HeLa cell lysate using bead-coupled phospho-GST-Tarp. The fusion protein 
was phosphorylated in vitro with recombinant human SRC. Input shows Tarp loading (bead coupled, black arrowheads) and SHC1 and NCK2 loading 
in HeLa cell lysate (black arrowheads). Pulled-down SHC1 and NCK2 are indicated by open arrowheads. SHC1 was only pulled down in lanes where 
Tarp was phosphorylated (indicated as p-Tarp). NCK2 was only pulled down with p-Tarp L2. As a control, beads were phosphorylated in the absence of 
GST-Tarp and did not pull down SHC1. (C) Western blot showing coimmunoprecipitation of SHC1 (white arrowheads) and Tarp (black arrowhead) after 
infection of HeLa or End1/E6E7 cells (C. trachomatis L2, MOI 500) for 60 min.149 Tarp phospho-interactome • Mehlitz et al.
Figure 4.  SHC1, MEK, and ERK are activated during early chlamydial infection. Western blots showing SHC1 phosphorylation on tyrosine residues 
Y239/240  (p-SHC1
Y239/240,  white  arrowheads)  and  Tarp  phosphorylation  (p-Tarp,  black  arrowheads)  during  a  time-course  infection  experiment   
(C. trachomatis L2, MOI 200; HeLa cells) (A) and a control experiment using C. pneumoniae TWAR (MOI 200, HeLa cells) showing only marginal SHC1 
phosphorylation on tyrosine residues Y239/240 (p-SHC1
Y239/240, white arrowheads) (B). Tarp phosphorylation was determined through use of a 
tyrosine phosphorylation–specific antibody. Hsp60 was used as an infection control (gray arrowhead). (C) Densitometric quantification of SHC1 
p52 Y239/240 phosphorylation. Values were calculated from A and B and normalized to total SHC1 p52 (n = 2, error bars indicate standard error [SE]).   
(D) MEK (white arrowheads) and ERK (black arrowheads) phosphorylation during a time-course infection experiment (C. trachomatis L2, MOI 200; HeLa cells). 
MEK and ERK show a phosphorylation peak at 5 min. Densitometric quantification of MEK phosphorylation (E) and ERK phosphorylation (F). Values were 
calculated from D and normalized to total MEK and ERK, respectively (n = 2, error bars indicate SE). All values are normalized to the “5 minutes” infection 
time point. (G and H) Western blots showing MEK (G) and ERK phosphorylation (H) during an infection time course (C. trachomatis L2, MOI 200; HeLa cells). 
Cells were either treated with siRNA against Luciferase (control) or SHC1. MEK and ERK activation were reduced upon infection. (A, B, G, and H) Controls (N)   
were mock infected with SPG for 60 min.JCB • VOLUME 190 • NUMBER 1 • 2010   150
of  MEK/ERK  phosphorylation  such  as  TNF  and  EGF   
(Fig. S2, D and E). SHC1 knockdown resulted in a 90–95%   
reduction at the protein level (Fig. S2 F) and did not affect   
adhesion, invasion, inclusion formation, or numbers of progeny   
(Fig. S2 G). Our results show that SHC1 phosphorylation dur-
ing early infection is Tarp dependent. Furthermore, SHC1 is   
recruited immediately after infection, where it is not directly 
needed for adhesion, invasion, inclusion formation, or bacterial 
propagation. Rather, SHC1 plays a prominent role in early   
C. trachomatis–induced MEK and ERK activation.
SHC1 activation and its transcriptional 
regulation during infection
SHC1 activation is known to modulate survival, proliferation, 
and migration by transcriptional regulation, depending on the 
stimulus (Guo and Giancotti, 2004). Thus, we decided to inves-
tigate the influence of SHC1 activation on transcription upon   
C. trachomatis cell entry. Because of the expected delay be-
tween MEK/ERK activation and its transcriptional response, 
experiments were performed at 4 h pi (Fig. S2 H), a time point 
at which the host cell exhibits a strong transcriptional response 
but bacteria are still largely metabolically inactive (EB to RB 
conversion takes place at 8–10 h; Mathews et al., 1999). Using 
human DNA microarrays, we determined genes that were dif-
ferentially expressed during infection of either control (without 
knockdown) or SHC1 knockdown cells. First, we analyzed in-
fected versus noninfected HeLa cells at 4 h pi, revealing 182 
differentially regulated genes: 76 genes were down-regulated 
(Fig. 5 A, top left green circle) and 106 genes were up-regulated 
(Fig. 5 A, bottom right red circle) in response to infection. Second, 
we compared infected SHC1 knockdown and infected Lucifer-
ase (control) knockdown HeLa cells, which indicates regulation 
of 449 SHC1-dependent genes: 332 genes were down-regulated 
(Fig. 5 A, top right green circle), whereas 117 genes were up-
regulated (Fig. 5 A, bottom left red circle). The observed   
approximately threefold increase of down-regulated genes as 
compared  with  up-regulated  genes  upon  infection  of  SHC1 
knockdown indicates a strong activating potential of SHC1 on 
gene expression. Interestingly, infection of SHC1 knockdown 
cells down-regulated approximately fourfold more genes than 
infection alone (Fig. 5 A, green circles), most likely due to more 
genes being SHC1 rather than infection dependent. A comparison 
of genes regulated between all conditions (gray areas) identified 
a total of 21 SHC1- and infection-dependent genes (Fig. 5 A, 
gray overlapping areas; and Table S2).
Functional  analysis  of  the  21  differentially  regulated 
genes using IPA revealed genes associated with apoptosis and 
cell growth regulation, with eight genes assigned to each cate-
gory (Fig. 5 B and Table S2). Indeed, these functional gene 
types were significantly enriched (P < 0.01) in this gene subset 
in comparison to the extended gene set, i.e., 10% of the 610 
genes versus 40% of the 21 genes were apoptosis related   
(Fig. 5 C). Surprisingly, IPA analysis also indicated that, among 
these 21 genes, nine genes are associated with MEK/ERK sig-
naling,  whereas  12  genes  are  controlled  by  other  pathways   
(Fig. 5 B, Fig. S3, and Table S2). Regulation of the majority of 
these genes was confirmed using real-time quantitative RT-PCR 
(qRT-PCR; Fig. S4 and Table S3). Thus, our transcriptional data 
suggest that SHC1 activation is involved in regulation of apop-
tosis and cell growth–related genes.
Further analysis of the 21-gene subset revealed four dis-
tinct groups (Fig. 5 B and Table S2): group 1 comprises tran-
scripts less abundant upon infection and more abundant in 
infected SHC1 knockdown cells (Fig. 5 D). Therefore, expres-
sion of the genes in group 1 is likely inhibited by SHC1 activa-
tion. In contrast, group 3 comprises transcripts more abundant 
upon infection and less abundant in infected SHC1 knockdown 
cells (Fig. 5 D). Consequently, expression of genes in group 3 is 
likely enhanced by SHC1 activation. Groups 2 and 4 include 
transcripts  either  less  abundant  (group  2)  or  more  abundant 
(group 4) after both infection and SHC1 knockdown in infected 
cells (Fig. 5 D). This can be explained by infection-dependent 
regulation of these genes in a SHC1-independent manner, counter-
acted by a SHC1-dependent regulation. Consequently, knockdown 
of SHC1 in infected cells leads to an enforced regulation due to 
the remaining SHC1-independent effects. Thus, our data has 
identified opposing gene regulatory circuits during C. trachomatis 
infection: being dependent or independent of SHC1.
SHC1 activation is a survival stimulus
To further examine the role of SHC1 in early C. trachomatis– 
induced cell survival, we investigated the effect of SHC1 knock-
down on host apoptosis after C. trachomatis entry (Fig. 6). For 
this purpose, TNF was added at 6 h pi for a duration of 4 h, 
i.e., 2 h after the observed transcriptional regulation changes   
(Fig. S2 H). Apoptosis induction levels in a combination of 
SHC1 or Luciferase (control) knockdown cells infected with 
either C. trachomatis or C. pneumoniae were determined using 
three different readouts: poly (ADP-ribose) polymerase (PARP) 
cleavage (Fig. 6, A and B), cytokeratin 18 cleavage (Fig. 6,   
C and D), and terminal deoxynucleotidyl transferase activity   
using the TUNEL assay (Fig. 6, E and F). C. trachomatis– 
infected  cells  display  the  highest  degree  of  apoptosis  resis-
tance under Luciferase (control) knockdown conditions. This 
inhibitory  phenotype  was  significantly  reduced  under  SHC1 
knockdown conditions using all three assays (Fig. 6, B, D, and F).   
Although  SHC1  dependence  was  apparent  for  C.  tracho-
matis at the early stages of infection, evidence was lacking for   
C. pneumoniae, which exhibited a comparably diminished degree 
of apoptosis resistance (Fig. 6, B, D, and F) and, notably, expresses 
a Tarp protein devoid of SHC1 phospho-binding sites (Clifton   
et al., 2005). Thus, our data demonstrate that C. trachomatis, but 
not C. pneumoniae, is able to confer early apoptosis resistance 
to infected host cells in an SHC1-dependent manner.
Discussion
Here, we describe the use of protein microarrays comprising 
nearly every human SH2 and PTB domain to quantitatively   
assess Tarp-mediated interactions. Tarp was found to have the 
capacity to interact with many different SH2 domain–containing 
proteins,  which  suggests  that  Tarp  contributes  substantially 
to phosphorylation-dependent signaling. In total, we discov-
ered 23 novel in vitro binding partners of Tarp and confirmed 151 Tarp phospho-interactome • Mehlitz et al.
In the nonphosphorylated state, Tarp showed serovariant- 
dependent affinity for host SH2 domain–containing proteins. 
ABL2 (ARG) was found to be the strongest interaction partner   
shared by both serovariants (D and L2). The ABL kinases   
can be activated through interaction of their SH2 domains with 
cellular substrates (Lewis and Schwartz, 1998; Barilá et al., 
2000). ABL1 and ABL2 have been shown to be among the 
human kinases that phosphorylate Tarp (Elwell et al., 2008; 
two (VAV2 and PI3K) that had previously been identified. High- 
affinity interactions with two proteins, the serovariant L2-specific 
protein NCK2 and the serovariant D and L2 common interaction 
partner SHC1, were experimentally validated, and the interaction 
of Tarp with SHC1 was studied in greater detail. We found that the 
Tarp–SHC1 interaction plays a direct role in conferring resistance 
to apoptosis in infected cells. Together, these data extend our under-
standing of how Tarp modulates host cell function.
Figure 5.  Apoptosis and cell growth genes are regulated in an SHC1-dependent manner. (A) HeLa cells were infected for 4 h (C. trachomatis L2, MOI 20) 
before RNA isolation and array hybridization. Gene expression profiles of infected versus noninfected cells (Inf (vs. NI)) were compared with infected 
SHC1 knockdown versus infected Luciferase knockdown cells (SHC1 KD + Inf (vs. Luci KD + Inf)) to determine infection and SHC1-dependently regulated 
genes (n = 2, each with dye swap). In total, 21 genes are regulated in both a SHC1- and infection-dependent manner (up-regulated genes are shown in 
red, down-regulated genes in green). (B) The 21 genes that correlate with both infection and SHC1 signaling were further analyzed using the IPA soft-
ware. Of these, eight genes are grouped into the functional category “apoptosis” and another eight genes are assigned to the category “cell growth.” 
(C) Gene enrichment analysis of the overlapping genes (21) compared with all regulated genes (610). Both functional categories “apoptosis” and “cell 
growth” are significantly enriched in the 21 overlapping genes (as determined by Fisher’s exact test). (D) Model of the role of SHC1 during early infection- 
mediated gene regulation. C. trachomatis activates SHC1 leading to four groups of regulated genes. Expression of group 1 genes is likely inhibited by 
SHC1 activation, explaining their up-regulation after SHC1 knockdown in infected cells. In contrast, gene expression in group 3 is likely enhanced by SHC1 
activation, causing a down-regulation of group 3 genes after SHC1 knockdown in infected cells. Genes of groups 2 and 4 show an additional regulation 
by C. trachomatis infection independent of SHC1, which remains after SHC1 knockdown in infected cells.JCB • VOLUME 190 • NUMBER 1 • 2010   152
Figure 6.  SHC1 knockdown sensitizes early infected cells to apoptosis. (A) Western blots showing TNF-induced PARP cleavage (black arrowheads) in 
HeLa cells with Luciferase or SHC1 knockdown after C. trachomatis infection (MOI 50) for 6 h and an additional induction of apoptosis for 4 h (25 ng/ml 
TNF and 10 µg/ml cycloheximide). Actin and Hsp60 were used as loading control (white arrowheads). Infection with C. trachomatis L2 blocked PARP 
cleavage in infected Luciferase-transfected HeLa cells, whereas SHC1 knockdown sensitizes infected cells to apoptosis as indicated by PARP cleavage. 
(B) Quantification of PARP cleavage in C. trachomatis and C. pneumoniae infection from chemiluminescence imager recorded blots (data from A and not 
depicted, n = 3, error bars indicate SE). Band signals from PARP and cleaved PARP were measured using AIDA software, and the ratio was calculated. 
The ratio of apoptosis inhibition in uninfected TNF-stimulated versus infected TNF-stimulated cells is depicted. C. trachomatis–infected control cells show a 153 Tarp phospho-interactome • Mehlitz et al.
high degree of apoptosis resistance, which is significantly reduced upon SHC1 knockdown. In contrast, C. pneumoniae–infected cells exhibit a diminished 
apoptosis resistance, independent of SHC1. (C and E) Immunostainings showing TNF-induced apoptosis in HeLa cells with Luciferase or SHC1 knockdown 
after infection with C. trachomatis and apoptosis induction (identical conditions to A). SHC1 knockdown sensitizes infected cells to apoptosis, whereas 
apoptosis is blocked in infected control cells. Apoptosis induction was assessed by cytokeratin 18 cleavage (red) and TUNEL assay (green), respectively. 
Nuclei are stained blue with Hoechst 33342. Image area: 450 µm × 450 µm. (D and F) Quantification of cells positive for cytokeratin 18 cleavage (data 
from B and not shown; n = 2, error bars indicate SE) and TUNEL (data from D and not depicted; n = 2, error bars indicate SE), respectively. A mean of 
10,000 cells per condition were analyzed. Apoptosis inhibition is depicted as in B. C. trachomatis infection leads to apoptosis inhibition in control cells, 
but not in SHC1 knockdown cells. In contrast, C. pneumoniae fails to block apoptosis in both control and SHC1 knockdown cells.
 
Jewett et al., 2008; Mehlitz et al., 2008). Consequently, the 
interaction between nonphosphorylated Tarp and ABL, leading 
to subsequent activation of ABL, may constitute an initial trig-
ger for Tarp phosphorylation (see model in Fig. S5; Hantschel 
et al., 2003; Nagar et al., 2003). It has previously been re-
ported that infection of ABL/ARG
/ knockout mouse fibro-
blasts  leads  to  a  50%  reduction  of  Tarp  phosphorylation, 
which suggests that ABL could be the initial Tarp kinase (Elwell 
et al., 2008). Interestingly, phosphorylation of the H. pylori 
protein CagA and the EPEC effector Tir was also shown to involve 
ABL (Swimm et al., 2004; Poppe et al., 2007). Furthermore,   
CagA, ABL, and CRKII have been shown to physically inter-
act (Tammer et al., 2007).
The  nonphosphorylated  state  of Tarp  is  short-lived,  as 
Tarp is phosphorylated immediately after translocation (Clifton 
et al., 2004). Here, we demonstrate that this phosphorylation leads   
to a dramatic increase of SH2 domain-mediated interactions. 
Accordingly, the Tarp phospho-interactome has a degree of 
complexity similar to that of the ERBB family of receptor 
tyrosine kinases (Jones et al., 2006). For example, Tarp D and   
L2 show similar numbers of interaction partners as ERBB4 and 
ERBB3, respectively.
Previously, only VAV2 and the regulatory subunit of PI3K 
have been identified as interaction partners of phosphorylated 
Tarp (Lane et al., 2008). Here, we confirmed these interactions 
using our SH2/PTB domain microarrays. Moreover, we found 
that Tarp L2 interacts with several host kinases previously im-
plicated in Tarp phosphorylation, corroborating Tarp L2 as a 
promiscuous  phosphorylation  substrate  (Elwell  et  al.,  2008; 
Jewett et al., 2008).
Comparison of Tarp D and L2 interactions revealed SHC1 
as one of the strongest partners for both serovariants, which 
suggests a general role for SHC1 in C. trachomatis infections. 
SHC1, which has not previously been shown to interact with 
Tarp, is also involved in EGFR signaling, leading to MEK/ERK 
activation upon stimulation with EGF or TNF. MEK/ERK acti-
vation, an emerging theme in the chlamydial infection process, 
was first shown to be involved in glycerophospholipid acquisi-
tion by C. trachomatis (Su et al., 2004) and, more recently, as 
an important anti-apoptotic mechanism (Paland et al., 2008). 
We found pronounced activation of MEK and ERK shortly after 
infection coincident with phosphorylation of Tarp and SHC1. 
Previous work suggested that rapid phosphorylation of ERK 
during chlamydial infection is linked to up-regulation of the 
anti-apoptotic protein MCL-1 (Rajalingam et al., 2008), which 
we found to be independent of SHC1 (unpublished data). More-
over, in our previous work, activation of both MEK and ERK 
was shown to be necessary for C. trachomatis at an advanced 
stage of infection; however, this activation was uncoupled from 
upstream signaling by RAS and RAF (Gurumurthy et al., 2010). 
MEK activation is thought to be crucial during infections with 
H. pylori (Hatakeyama, 2008) and has been shown to be initi-
ated through interaction of CagA with SHP-2 (Higashi et al., 
2002), CRK (Suzuki et al., 2005), GRB2 (Mimuro et al., 2002), 
and c-MET (Churin et al., 2003).
Here, we describe the direct recruitment of SHC1 and the 
subsequent activation of MAP kinase family members MEK 
and  ERK  in  the  early  stages  of  a  C.  trachomatis  infection. 
However, C. trachomatis Tarp may very well trigger additional 
pathways causing MEK/ERK activation (Fig. S3). Candidate 
molecules are the adaptor protein CRKL, which is capable of 
activating ERK through b-RAF upon integrin signaling (Guo 
and Giancotti, 2004); the GTPase RASA1, directly activating 
b-RAF (Schubbert et al., 2007); and p56LCK, which bypasses 
RAS/RAF/MEK  and  activates  ERK  in  a  PKC-dependent 
manner during Mycobacterium leprae infection (Tapinos and 
Rambukkana,  2005). All  three  factors  were  found  to  recog-
nize phospho-Tarp in this study (Fig. 1, Table S1, and model in   
Fig. S5). SHC1 knockdown led to significant changes in the 
expression of anti-apoptotic and growth-related genes in the con-
text of C. trachomatis infection. As deduced from knowledge-
based pathway analysis, SHC1 signaling depends only partially 
on the MEK/ERK cascade, whereas the remaining genes are 
regulated by additional signaling pathways (Figs. S3 and S5). 
This is consistent with our observation of a significant reduction 
in C. trachomatis–induced cell survival upon SHC1 knockdown 
despite a residual activation of MEK and ERK. It is tempting to 
argue that this SHC1-mediated gene regulation is a MEK/ERK-
independent branch of the EGFR-mediated signaling cascade. 
In H. pylori infection, a major outcome of CagA translocation 
appears to be regulation of growth-dependent genes (Keates et al.,   
1999; Mimuro et al., 2002). Thus, induction of growth signaling   
seems  to  be  an  important  function  of  tyrosine-phosphorylated   
effectors. Future investigations are required to clarify whether 
this also holds true for other effectors like EPEC Tir, Anaplasma   
phagocytophilum AnkA, or Vaccinia virus A36R (Backert et al., 
2008). Collectively, our observations support a model in which 
activation  of  both  MEK/ERK-dependent  and  independent 
growth signaling cascades plays a central role in C. trachomatis–
induced cell survival. This assigns an important anti-apoptotic 
function to the interaction between phospho-Tarp and SHC1 
during the early stage of infection.
An alternative approach to assess protein interactions with 
tyrosine-phosphorylated  peptides  from  CagA,  Tir,  Tarp,  and 
BepD-F used differential mass-spectroscopy (SILAC; Selbach 
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Antiserum against Tarp was raised by immunization of rats with GST-Tarp 
fusion  protein  (Biogenes).  Monoclonal  anti–C.  trachomatis  OMP1  was   
obtained from the University of Washington. GST-Tarp was constructed by 
PCR amplification of nucleotides 6–818 of C. trachomatis LGV L2 Tarp or 
1–939 of C. trachomatis D Tarp and ligation of the product into pGEX4T-3 
(GE Healthcare) using dinucleotide sticky-end cloning. Purification of GST-
Tarp was performed according to manufacturer’s instructions using glutathi-
one sepharose (GE Healthcare).
Peptide synthesis and protein microarrays
Peptides were synthesized as described previously (Jones et al., 2006), 
purified to >95% by preparative reverse phase HPLC, quality controlled 
via matrix-assisted laser desorption/ionization time-of-flight mass spectrom-
etry (Thermo Fisher Scientific), and labeled on their N termini with 5- (and 
6)-carboxytetramethylrhodamine (5(6)-TAMRA) from AnaSpec.
We have previously described cloning, expressing, and purifying 
virtually every human SH2 and PTB domain, as well as preparing micro-
arrays of these domains on chemically derivatized glass surfaces (MacBeath 
and Schreiber, 2000; Jones et al., 2006). In brief, the coding regions for 
each domain were cloned from human cDNA, and the corresponding proteins 
were produced recombinantly in E. coli using the T7 expression system. 
Each domain features an N-terminal His6 tag, as well as a thioredoxin tag 
to facilitate the high-level production of soluble protein. After purifying 
each domain from large-scale bacterial culture (0.5 liter), we assessed its 
purity by SDS-PAGE and its aggregation state by size exclusion column 
chromatography. In the current version of our arrays, we eliminated domains 
that were impure or did not contain soluble, monomeric protein. Notably, SH2 
domains derived from the signal transducers and activator of transcription 
(STAT) and suppressors of cytokine signalling (SOCS) families of proteins 
did not behave well. By cloning larger portions of STAT1 and STAT2 that 
included  their  entire  SH2  domain–containing  cores  (Mao  and  Chen, 
2005), we obtained soluble, monomeric material for these two proteins.   
In addition, we cloned, expressed, and purified the N-terminal domain of 
CBL (Meng et al., 1999), which contains a noncanonical SH2 domain.   
In total, 133 domains representing 103 proteins were used in these studies.
To facilitate the rapid and automated processing of protein micro 
arrays, we used a NanoPrint microarrayer (TeleChem International, Inc.) to 
spot our proteins in quadruplicate on aldehyde displaying glass substrates, 
cut to the size of a microtiter plate (112.5 mm × 74.5 mm × 1 mm; Erie 
Scientific). 96 separate arrays were prepared on each glass substrate, and 
the glass was attached to the bottom of a bottomless microtiter plate using 
an intervening silicone gasket (Grace Bio-Labs). Two 16 × 17 microarrays 
were required to accommodate all 133 domains, as well as the appropriate 
controls (His6-tagged thioredoxin and buffer). Proteins were spotted in quadru-
plicate at a high concentration (40–200 µM), and a low concentration   
(200 nM) of cyanine 5–labeled bovine serum albumin was included in each 
sample to facilitate image analysis. Arrays were stored before use at 80°C.
Immediately before use, the plates were quenched with buffer A   
(20 mM Hepes, 100 mM KCl, and 0.1% Tween-20, pH 7.8) containing 
1% BSA (wt/vol) for 30 min at room temperature, followed by several 
rinses with buffer A. Arrays were probed with eight different concentrations 
of labeled peptides (5 µM, 3 µM, 2 µM, 1 µM, 500 nM, 200 nM, 100 nM, 
and 10 nM) dissolved in buffer A. Peptide solution was removed after a 1-h 
incubation at room temperature, and arrays were washed with 150 ml of 
buffer A for 10 s. Arrays were rinsed briefly with double-distilled H2O and 
spun upside down in a centrifuge for 1 min to remove residual water.
Protein microarrays were scanned at 10-µm resolution using a scan-
ner (LS400; Tecan). Spots were defined using the Cy5 image, and the 
mean  fluorescence  of  each  spot  was  calculated  from  the  5(6)-TAMRA   
image. We have previously shown that probing a protein microarray with 
a single concentration of a labeled probe can produce very misleading   
results (Gordus and MacBeath, 2006). We therefore probed our arrays 
with eight concentrations of each peptide and fit the resulting spot intensi-
ties, Fobs, to the following equation:
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where F0 is the background fluorescence, Fmax is the maximum fluorescence at 
saturation, [pep] is the total peptide concentration, and KD is the equilibrium 
dissociation constant. For each peptide, we fit all 133 curves, one for each 
domain. Interactions were considered specific if the data fit well to Eq. 1  
(R
2 > 0.9), with KD < 2 µM and Fmax at least twofold higher than the mean   
fluorescence of control spots (His6-tagged thioredoxin). The resulting data were 
displayed graphically using Cytoscape 2.1 (http://www.cytoscape.org/).
partners reported here, notably the previously reported inter-
action with PI3K. Differences in methodological approach are 
most likely responsible for this small degree of overlap. Our array 
analysis provides a list of all possible direct interaction partners. 
In contrast, immunoprecipitation coupled with mass spectrometry 
does not discriminate between direct and indirect interactions, 
owing to secondary protein contacts in signaling complexes. 
In addition, our approach provides a global view of biophysical 
interactions, whereas the approach of (Selbach et al., 2009)   
focused on a specific cell type and hence was dependent on the 
proteins being expressed in their cell of interest. Nonetheless, 
both approaches provide important and complementary infor-
mation on the complexity of host–pathogen interactomes.
Here, we have shown that global interactome studies pro-
vide a powerful approach to uncover host cell counterparts of 
bacterial effector proteins, helping to increase our understanding 
of the mechanisms of host–microbe interactions. To our knowl-
edge, this paper presents the first comprehensive interactome 
study of a phosphorylated bacterial effector protein using SH2/
PTB domain microarrays. Our study not only confirmed several 
known interactions but also revealed an extensive repertoire of 
novel high- and low-affinity interactions with phosphorylated 
and nonphosphorylated versions of C. trachomatis Tarp. In addi-
tion, these interactions varied substantially between serovars. 
We focused here on just one of the many possible Tarp–cellular 
protein interactions to substantiate our hypothesis. The remain-
ing data reported here provide a wealth of additional hypotheses 
to test regarding Tarp-mediated cellular signaling induced by 
chlamydial infection.
Materials and methods
Cell lines and bacteria
HeLa  (American  Type  Culture  Collection  [ATCC]  No.  CRM-CCL-2)  and 
End1/E6E7 (ATCC No. CRL-2615) cervical epithelial cells were grown in 
DME (Invitrogen) supplemented with 10% fetal calf serum, 5 mM l-glutamine, 
and 1 mM sodium pyruvate (Invitrogen). C. trachomatis Lymphogranuloma 
venereum (LGV) biovar strain L2/434/Bu (ATCC No. VR-902B), C. tracho-
matis trachoma type D strain UW-3/Cx (ATCC No. VR-885), and C. pneu-
moniae TWAR strain CDC/CWL-029 (ATCC No. VR-1310) were purified 
from confluent HeLa monolayers. In brief, HeLa cells were grown to 80% con-
fluency and were inoculated for 2 h with the respective C. trachomatis strain. 
For infections with C. pneumoniae, inoculated cells were incubated at 
22°C for 1 h on a shaker, centrifuged (500 rpm at 35°C) for 1 h, and then 
incubated  for  2  h  at  35°C.  The  medium  was  replaced  by  infection   
medium (DME; 5% fetal calf serum, 5 mM l-glutamine, 1 mM sodium pyru-
vate, and 1 µg/ml cycloheximide), and growth was allowed for 48 h. Cells 
were mechanically detached, and bacteria were released using 2–5 mm 
glass beads (Carl Roth GmbH + Co. KG). Low-speed supernatant (5 min at 
4,000 g and 4°C) was subjected to high-speed centrifugation (25 min at 
40,000 g and 4°C) to pellet the bacteria. Bacteria were washed twice with 
10 ml SPG (220 mM sucrose, 50 mM sodium phosphate, and 5 mM gluta-
mate, pH 7.4), aliquoted, and stored at 80°C in SPG.
Reagents, antibodies, and constructs
Chemicals were obtained from Sigma-Aldrich. Recombinant human TNF 
was  obtained  from  BD.  Antibodies  against  -actin,  ERK2,  p-ERK1/2, 
MEK1/2, p-MEK1/2, PARP-1/2, SHC, p-SHC pY239/240, p-Tyr PY99, 
NCK1/2, and GST were acquired from Santa Cruz BioTechnology, Inc., or 
Cell Signaling Technology. Antibodies against the M30 epitope of cleaved 
cytokeratin 18 and against bacterial Hsp60 were obtained from Enzo Life 
Sciences, Inc. Secondary Cy2-conjugated antibodies against rabbit IgG, 
mouse IgG, and Cy5-conjugated antibodies against rabbit IgG and mouse 
IgG were obtained from Jackson ImmunoResearch Laboratories, Inc. Alexa 
Fluor 532 phalloidin for staining of actin was obtained from Invitrogen. 155 Tarp phospho-interactome • Mehlitz et al.
two-color dye-reversal ratio hybridizations on arrays containing 44,000 
human genes (AMADID 010646; Agilent Technologies) in biological dupli-
cates. RNA labeling was performed with a Fluorescent Linear Amplification 
kit (Agilent Technologies). The labeling efficiency was verified at A552nm for 
Cy3-CTP and A650nm for Cy5-CTP with a Nanodrop photometer (Kisker- 
Bioteck). Before hybridization, complimentary RNA of each product was 
fragmented and mixed with control targets and hybridization buffer ac-
cording to the manufacturer’s instructions (Agilent Technologies). Hybridiza-
tions were performed overnight (17 h) at 60°C. The slides were washed   
according to the manufacturer’s instructions, and scanning of microarrays 
was  performed  at  5-µm  resolution  using  a  microarray  laser  scanner   
(Agilent Technologies).
Data analysis was performed on the Rosetta Resolver system 7.2 
(Rosetta Biosoftware). Ratio profiles were generated from raw scan data 
by a processing pipeline, which includes preprocessing (feature extraction) 
and postprocessing (Rosetta Resolver) of data and error model adjustments 
to the raw scan data. Ratio profiles were combined in an error-weighted 
fashion (Rosetta Resolver) to create ratio experiments. Expression patterns 
were identified using stringent analysis criteria of 1.6-fold expression   
cutoffs of the ratio experiments and an anti-correlation of the dye reversal 
ratio profiles. Anti-correlation was determined by using the compare func-
tion to match two different hybridizations pairs and to decide how similar 
or dissimilar they were. By combining the first and the second criteria 
of analysis, data points with a low p-value (P < 0.01) were filtered out, 
making the analysis robust and reproducible. Additionally, by using this 
strategy, the data selection was independent of error models implemented 
in the Rosetta Resolver system.
For qRT-PCR, mRNA was isolated as described above. 10 µl mRNA 
was DNaseI-digested with RNase-free DNaseI (Fermentas) according to 
the manufacturer’s instructions. Digested mRNA was phenol/chloroform 
purified. In brief, 180 µl of RNase-free water (Millipore/Synergy) and   
200 µl of phenol/chloroform (Roth) were added to the 20-µl digestion re-
action and vortexed. Samples were phase separated at 12,000 g (4°C for 
10 min), and the supernatant was combined with 200 µl of chloroform 
followed by vortexing. After repeated phase separation, mRNA was pre-
cipitated using 1/10 volume of 3 M sodium acetate and 2 volumes of 
80% ethanol followed by centrifugation at 14,000 g (4°C for 15 min). The 
supernatant was removed, and the pellet was air dried in a clean bench 
environment and resuspended in 50 µl of RNase-free water. mRNA was 
reverse transcribed using the Revert Aid First Strand Synthesis kit (Fermen-
tas) according to the manufacturer’s instructions and was diluted 1:10 with 
RNase free water. qRT-PCR was set up with Absolute QPCR SYBR Green 
Mix (Thermo Fisher Scientific) according to the manufacturer’s instructions. 
qRT-PCR was performed on a Step One Plus device (Applied Biosystems), 
and data were analyzed using the Ct method, Step One Plus software 
package  (Applied  Biosystems),  and  Excel.  Endogenous  controls  were 
GAPDH and L13a. Splice variant-specific primers were designed using 
National Center for Biotechnology Information Primer Blast or Primer 3 
(Rozen and Skaletsky, 2000; Table S4).
Apoptosis induction and detection, data acquisition and analysis
HeLa cells were seeded in 12-well plates and infected with C. trachomatis 
L2 at MOI 50 for 6 h, then apoptosis was induced by the addition of TNF 
(25 ng/ml) and cycloheximide (10 µg/ml) for an additional 4 h (Fig. S2 H). 
Infection with C. pneumoniae TWAR (MOI 50) was assisted by centrifuga-
tion (1 h at 500 g and 35°C), followed by 5 h of incubation before apopto-
sis induction as described for C. trachomatis. For the PARP cleavage assay, 
cells were directly lysed in 2× sample buffer (Laemmli) and heated at 95°C 
for 10 min. For quantification, Western blots were imaged using a biolumi-
nescence reader (LAS-3000; Fujifilm) and the Image Reader LAS-3000 
software  (Fujifilm).  Respective  bands  and  their  lane  backgrounds  were 
measured using the Advanced Image Data Analyzer (AIDA) software, and 
the ratio of cleaved PARP to the total PARP amount was calculated. For the 
cytokeratin 18, cleavage and the TUNEL assays cells were spun down be-
fore staining. Cytokeratin 18 staining was done as described in the immuno-
fluorescence section, and TUNEL staining was performed according to 
manufacturer’s instructions (DeadEnd Fluorometric TUNEL System; Promega) 
with green fluorescence of apoptotic cells due to fluorescein-12-dUTP label-
ing. Nuclei were stained blue with Hoechst 33342. Images of stained PBS 
stored cells were acquired at RT using an automated microscope (Scan^R 
system [Olympus] consisting of an inverted microscope [IX81; Olympus], 
charge-coupled device camera [C4742-80-12AG; Hamamatsu] and the 
Scan^R acquisition software) at 10× magnification (UPlanS Apo 10×/0.40 
NA lens; Olympus). Cells positive for cleaved cytokeratin 18, TUNEL, and 
nuclei were counted using ImageJ, and the ratio (cleaved cytokeratin 18 or 
In vitro phosphorylation, precipitation, immunoprecipitation,  
and immunoblotting
GST-Tarp  was  phosphorylated  while  the  beads  coupled  to  glutathione 
sepharose (GE Healthcare). In brief, GST-Tarp beads were incubated for   
30 min at 30°C with recombinant human c-SRC (Cell Signaling Technol-
ogy) in kinase buffer (25 mM Hepes, pH 7.0, 150 mM NaCl, 10 mM 
MgCl2, 1% Nonident P40, 5 mM dithiothreitol, 1 mM Na3VO4, 1× Com-
plete protease inhibitors, and 6 mM ATP). GST-Tarp beads were washed 
three times with PBS and incubated with lysate from 10
7 cells (50 mM Tris, 
pH 7.5, 150 mM NaCl, 1% Nonident P40, 0.5% sodium deoxycholate, 
and 1× Complete protease inhibitors) for 2 h at 4°C. Proteins were eluted 
by incubation with 20 mM of reduced glutathione in 50 mM Tris, pH 8.0. 
Immunoprecipitation and Western blotting were performed according to 
standard procedures (Sambrook and Russel, 2001). Signal detection was 
done using ECL/Hyperfilm (GE Healthcare). Quantification was performed 
using ImageJ (National Institutes of Health) and Excel (Microsoft).
siRNA transfections
HeLa cells were transfected with SHC1 SMARTpool (Thermo Fisher Scien-
tific) or Luciferase siRNA (QIAGEN) using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions. Knockdown was confirmed 
via Western blotting 72 h after transfection.
Infection time courses
HeLa or End1/E6E7 cells were seeded into 12-well cluster plates at a den-
sity of 60–70%. Cells were serum starved for 24 h in serum-free growth 
medium before performing infection time-course experiments. Infection was 
performed at indicated MOIs with either bacteria or control mock-infected 
cells  (i.e.,  infected  with  C.  trachomatis  storage  buffer,  SPG).  C.  pneu-
moniae infections were synchronized by centrifugation for 1 h at 500 g 
and 4°C, and shifting to 35°C. Infection was stopped at the indicated 
times by removing the medium, rinsing quickly with prewarmed PBS, and 
immediately lysing in SDS loading buffer at 94°C for 5 min.
Immunofluorescence staining, invasion, inclusion formation,  
and progeny assays
For immunofluorescence, cells were either seeded in 24- or 12-well cluster 
plates with or without coverslips, and were infected in a humidified incuba-
tor at 35°C and 5% CO2 with MOIs indicated in the respective experi-
ments. Cells were fixed at indicated time points with 4% PFA, washed once 
with PBS, and stained. In brief, cells were permeabilized with 0.2% Triton 
X-100 or 0.1% saponin in PBS for 30 and 10 min, respectively, and were 
washed 3× with PBS for 5 min at RT. Cells were blocked with 2% FCS in 
PBS for 45 min and were stained with primary antibodies diluted in 2% 
FCS in PBS for 1 h at RT. After 3× washing with PBS, samples were incu-
bated with secondary antibodies for 1 h in blocking solution at RT in the 
dark.  After  one  short  wash  with  ddH2O,  samples  were  mounted  with 
Mowiol 4–88 (Carl Roth GmbH + Co. KG) and visualized at RT on a con-
focal microscope (photomultiplier equipped; TCS SPE; Leica) at 63× magni-
fication (HCX Plan-Apochromat with a 63×/1.40–0.60 oil objective lens; 
Leica) using acquisition software (LAS AF TCS SPE; Leica). Data were pro-
cessed with Photoshop (adjustment of brightness and contrast identical for 
all images; Adobe).
For measurement of invasion efficiency, inclusion formation, and 
progeny, HeLa cells were seeded in 12-well cluster plates and were siRNA 
transfected as described in “siRNA transfections.” On day 2, cells were 
split into three separate wells and then infected on day 4 at MOI 50 for in-
vasion assays or MOI 1 for inclusion formation and progeny counts. Inva-
sion assays were stopped at 1 and 10 h pi; cells were fixed with ice-cold 
methanol overnight at 20°C, stained for OMP1 and Hoechst 33342, 
and analyzed by automated microscopy (Scan^R system; Olympus) at 10× 
magnification. Data were processed using ImageJ and Excel.
Inclusion formation was quantified 24 h pi by manually counting the 
inclusion forming units (IFU) as inclusions per 40× field on a cell culture 
microscope (DM-IL; Leica). Progeny infections were grown for 48 h before 
glass bead lysis of host cells to release infectious particles and infection of 
fresh HeLa monolayers. After another 24 h of infection, cells were processed 
as described for inclusion formation. Data were processed with Excel.
RNA preparation, DNA microarrays, qRT-PCR, and experimental design 
and analysis
RNA from infected, uninfected, or transfected (and infected) HeLa cells was 
isolated with the RNAeasy kit (QIAGEN) according to the manufacturer’s 
instructions.  RNA  integrity  was  analyzed  using  a  Bioanalyzer  (2100; 
Agilent Technologies). DNA microarray experiments were performed as JCB • VOLUME 190 • NUMBER 1 • 2010   156
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